SeQuent Scientific Ltd
NSE:SEQUENT
SeQuent Scientific Ltd
Net Income (Common)
SeQuent Scientific Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
SeQuent Scientific Ltd
NSE:SEQUENT
|
Net Income (Common)
-₹1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Net Income (Common)
₹52.3B
|
CAGR 3-Years
34%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Net Income (Common)
₹37.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Net Income (Common)
₹89.1B
|
CAGR 3-Years
55%
|
CAGR 5-Years
21%
|
CAGR 10-Years
13%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Net Income (Common)
₹29.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
14%
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Net Income (Common)
₹12.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is SeQuent Scientific Ltd's Net Income (Common)?
Net Income (Common)
-1.3B
INR
Based on the financial report for Dec 31, 2023, SeQuent Scientific Ltd's Net Income (Common) amounts to -1.3B INR.
What is SeQuent Scientific Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-579%
Over the last year, the Net Income (Common) growth was -579%.